Pioglitazone Versus Metformin in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2015

Study Completion Date

April 30, 2015

Conditions
Type 2 Diabetes
Interventions
DRUG

Pioglitazone

15-45 mg/die

DRUG

Metformin

500-2000 mg/die

Trial Locations (1)

80138

Department of Geriatrics and Metabolic Diseases, Naples

All Listed Sponsors
lead

University of Campania Luigi Vanvitelli

OTHER

NCT00815399 - Pioglitazone Versus Metformin in Type 2 Diabetes | Biotech Hunter | Biotech Hunter